Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




DxS Will Identify EGFR Mutations in Lung Cancer Patients

By LabMedica International staff writers
Posted on 03 Jun 2009
DxS (Manchester, UK) and a global group of pharmaceutical companies have entered into an agreement to provide a companion diagnostic test kit for the Boehringer Ingelheim (Ingelheim, Germany) compound BIBW 2992 (Tovok). More...
The test identifies mutations of the epidermal growth factor receptor (EGFR) in patients with nonsmall cell lung cancer (NSCLC). DxS and Boehringer Ingelheim will work jointly to make a suitable companion diagnostic test kit globally available. Financial terms of the agreement were not disclosed.

BIBW 2992 is a novel tyrosine kinase inhibitor, which acts by irreversibly blocking the EGFR /HER2 receptors that are promoters of tumor growth. Patients with mutations in the EGFR gene will be more likely to respond to a medication that targets these receptors, thereby allowing doctors to prescribe the most effective and individual treatment. BIBW 2992 has demonstrated preclinical activity against erlotinib and gefitinib resistant mutations.

The DxS EGFR companion diagnostic is a real-time polymerase chain reaction (PCR) assay, designed to detect the most common mutations in the EGFR gene. It will be available in the summer of 2009 for Boehringer Ingelheim's global, multicenter phase III clinical trial for BIBW 2992.

The Boehringer Ingelheim group is a pharmaceutical company committed to researching, developing, manufacturing, and marketing products of therapeutic value for human and veterinary medicine.

DxS is a personalized medicine company providing molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It partners pharmaceutical companies to support the development and sales of targeted cancer therapies by providing biomarkers and companion diagnostics.

Related Links:

DxS
Boehringer Ingelheim



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Connectivity Solution
EKF Link
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.